Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIMELAPSE study of low-dose amitriptyline versus CBT-I for chronic insomnia with comorbid medical conditions
NL-OMON60315Phase 4Completed
- Sponsor
- Hospital Gelderse Vallei
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amitriptyline in chronic insomnia, sponsored by Hospital Gelderse Vallei. Started Oct 2024; status: completed.
02
Drugs
amitriptyline
03
Conditions
chronic insomnia
Beyond the preview
Go deeper on NL-OMON60315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60315.